InvestorsHub Logo
Followers 11
Posts 2417
Boards Moderated 2
Alias Born 02/24/2018

Re: None

Tuesday, 01/31/2023 11:23:59 AM

Tuesday, January 31, 2023 11:23:59 AM

Post# of 20299
Pfizer's stellar earnings report is out along with guidance for this year. Although overall demand for Covid related products is expected to decline significantly, the price for those products will rise once government subsidies stop later this year. Implications for Todos and Covid/long-Covid initiatives seem to point to a mixed bag.

https://www.cnbc.com/2023/01/31/the-covid-pandemic-drives-pfizers-2022-revenue-to-a-record-100-billion.html